Neuronetics: Q3 Earnings Snapshot
Update: 2025-11-04
Description
Neuronetics, a Pennsylvania-based medical device company, reported a $9 million net loss for Q3, but saw a revenue increase to $37.3 million. Despite the loss, the company remains optimistic about its technology's potential in treating psychiatric disorders. Looking ahead, Neuronetics projects revenue between $40-43 million for Q4 and $147-150 million for the full year, offering a glimmer of hope amidst financial uncertainty.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
